• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-Q filed by Sally Beauty Holdings Inc. (Name to be changed from Sally Hold

    2/9/26 4:06:31 PM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary
    Get the next $SBH alert in real time by email
    10-Q
    Q10001368458false--09-302026April 30, 2026http://fasb.org/srt/2025#ChiefExecutiveOfficerMember2480001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001368458us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2025-09-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMembersbh:SallyMemberus-gaap:EntityOperatedUnitsMember2024-10-012024-12-310001368458us-gaap:RetainedEarningsMember2024-10-012024-12-310001368458sbh:JohnGossMember2025-10-012025-12-310001368458us-gaap:InterestRateSwapMembersbh:SallyHoldingsMember2025-10-012025-12-310001368458us-gaap:FairValueInputsLevel2Memberus-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMember2025-09-300001368458sbh:UnallocatedMember2025-10-012025-12-310001368458us-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2025-12-310001368458us-gaap:AdditionalPaidInCapitalMember2024-10-012024-12-310001368458sbh:AccumulatedForeignExchangeContractsMember2025-09-300001368458us-gaap:RetainedEarningsMember2025-09-300001368458sbh:AssetBasedSeniorSecuredLoanFacilityMember2025-12-310001368458us-gaap:CommonStockMember2025-10-012025-12-310001368458us-gaap:AccumulatedTranslationAdjustmentMember2025-09-300001368458us-gaap:ForeignExchangeContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-10-012024-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2024-10-012024-12-310001368458us-gaap:AdditionalPaidInCapitalMember2024-12-310001368458sbh:SallyHoldingsMembersbh:TLBTwentyThirtyMember2025-12-310001368458us-gaap:OperatingSegmentsMembersbh:BeautySystemsGroupMember2024-10-012024-12-310001368458us-gaap:CommonStockMember2025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:HairCareMembersbh:BeautySystemsGroupMember2025-10-012025-12-3100013684582023-04-012023-04-300001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:SalonBusinessConsultantsMember2024-10-012024-12-310001368458us-gaap:DesignatedAsHedgingInstrumentMembercurrency:MXN2025-12-310001368458us-gaap:AdditionalPaidInCapitalMember2024-09-300001368458sbh:ShareRepurchaseProgram2017Member2025-05-012025-05-310001368458us-gaap:InterestRateSwapMember2025-09-3000013684582025-09-300001368458us-gaap:RetainedEarningsMember2024-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:ECommerceMember2024-10-012024-12-310001368458us-gaap:InterestRateSwapMembersbh:SallyHoldingsMember2023-04-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMember2025-10-012025-12-3100013684582025-12-310001368458us-gaap:FairValueInputsLevel2Membersbh:SeniorNotesDueTwoThousandAndThirtytwoMember2025-09-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:HairColorMember2025-10-012025-12-310001368458sbh:UnallocatedMember2024-10-012024-12-310001368458us-gaap:SalesRevenueNetMembersbh:OtherBeautyItemsMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2025-10-012025-12-310001368458us-gaap:FairValueInputsLevel2Membersbh:SeniorNotesDueTwoThousandAndThirtytwoMember2025-12-310001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001368458sbh:SallyBeautySupplyMemberus-gaap:OperatingSegmentsMember2024-10-012024-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:SalonBusinessConsultantsMember2025-10-012025-12-310001368458us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeContractMember2024-10-012024-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:StylingToolsAndSuppliesMembersbh:BeautySystemsGroupMember2025-10-012025-12-310001368458us-gaap:FairValueInputsLevel2Membersbh:TermLoanBDueTwoThousandAndThirtyMember2025-09-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMembersbh:HairColorMember2025-10-012025-12-310001368458us-gaap:SalesRevenueNetMembersbh:SkinAndCosmeticsMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMember2024-10-012024-12-310001368458us-gaap:FairValueInputsLevel2Memberus-gaap:OtherAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2025-09-300001368458us-gaap:FairValueInputsLevel2Memberus-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001368458sbh:BeautySystemsGroupMember2025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:NailMember2024-10-012024-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMembersbh:HairColorMember2024-10-012024-12-310001368458us-gaap:RetainedEarningsMember2025-10-012025-12-310001368458sbh:ShareRepurchaseProgram2017Member2024-10-012024-12-310001368458us-gaap:CommonStockMember2025-09-3000013684582026-02-040001368458us-gaap:SalesRevenueNetMembersbh:SkinAndCosmeticsMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2024-10-012024-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:NailMembersbh:BeautySystemsGroupMember2024-10-012024-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:ECommerceMember2024-10-012024-12-310001368458sbh:ShareRepurchaseProgram2017Member2025-10-012025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:ECommerceMember2025-10-012025-12-310001368458us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeContractMember2025-10-012025-12-310001368458us-gaap:FairValueInputsLevel2Memberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-3100013684582024-09-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMembersbh:HairCareMember2024-10-012024-12-310001368458sbh:SallyHoldingsMembersbh:TLBTwentyThirtyMember2025-10-012025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:OtherBeautyItemsMembersbh:BeautySystemsGroupMember2024-10-012024-12-310001368458us-gaap:FairValueInputsLevel2Memberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2025-09-300001368458us-gaap:ForeignExchangeContractMember2025-10-012025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2025-10-012025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:StylingToolsAndSuppliesMember2024-10-012024-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:ECommerceMember2025-10-012025-12-310001368458us-gaap:FairValueInputsLevel2Membersbh:TermLoanBDueTwoThousandAndThirtyMember2025-12-310001368458sbh:DentonTexasMember2024-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMembersbh:BeautySystemsGroupMemberus-gaap:EntityOperatedUnitsMember2024-10-012024-12-310001368458currency:GBP2025-12-310001368458us-gaap:RetainedEarningsMember2024-09-300001368458currency:EUR2025-12-310001368458us-gaap:ForeignExchangeContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2025-10-012025-12-310001368458us-gaap:InterestRateSwapMembersbh:SallyHoldingsMember2024-10-012024-12-310001368458us-gaap:OperatingSegmentsMembersbh:BeautySystemsGroupMember2025-10-012025-12-310001368458us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2025-12-310001368458us-gaap:SalesRevenueNetMembersbh:SkinAndCosmeticsMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMember2025-10-012025-12-310001368458us-gaap:AdditionalPaidInCapitalMember2025-10-012025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:OtherBeautyItemsMembersbh:SallyMember2024-10-012024-12-310001368458us-gaap:DesignatedAsHedgingInstrumentMembercurrency:EUR2025-12-310001368458us-gaap:OperatingSegmentsMember2025-10-012025-12-310001368458us-gaap:OperatingSegmentsMember2024-10-012024-12-310001368458sbh:DentonTexasMember2024-10-012024-12-310001368458us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherLiabilitiesMember2025-12-310001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-10-012025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMember2024-10-012024-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:HairCareMember2024-10-012024-12-310001368458us-gaap:FairValueInputsLevel2Memberus-gaap:OtherAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001368458currency:CAD2025-12-310001368458sbh:AccumulatedForeignExchangeContractsMember2025-12-310001368458us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2025-10-012025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:NailMember2025-10-012025-12-310001368458us-gaap:AccumulatedTranslationAdjustmentMember2025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:StylingToolsAndSuppliesMembersbh:BeautySystemsGroupMember2024-10-012024-12-310001368458us-gaap:CommonStockMember2024-10-012024-12-310001368458us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeContractMember2025-12-310001368458us-gaap:SalesRevenueNetMembersbh:OtherBeautyItemsMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMember2025-10-012025-12-310001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001368458us-gaap:AccumulatedTranslationAdjustmentMember2025-10-012025-12-310001368458us-gaap:CommonStockMember2024-09-300001368458us-gaap:RetainedEarningsMember2025-12-310001368458sbh:ShareRepurchaseProgram2017Member2025-12-310001368458us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:AccruedLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:HairColorMember2024-10-012024-12-310001368458us-gaap:ForeignExchangeContractMember2025-12-310001368458currency:MXN2025-12-310001368458sbh:SallyBeautySupplyMemberus-gaap:OperatingSegmentsMember2025-10-012025-12-310001368458us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001368458us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:AccruedLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2025-09-300001368458us-gaap:InterestRateSwapMembersbh:SallyHoldingsMember2023-04-012023-04-300001368458us-gaap:FairValueMeasurementsRecurringMember2025-09-300001368458us-gaap:SalesRevenueNetMembersbh:SkinAndCosmeticsMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2025-10-012025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMembersbh:BeautySystemsGroupMemberus-gaap:EntityOperatedUnitsMember2025-10-012025-12-3100013684582025-10-012025-12-3100013684582024-10-012024-12-310001368458us-gaap:CommonStockMember2024-12-310001368458us-gaap:InterestRateSwapMembersbh:SallyHoldingsMember2025-12-310001368458us-gaap:LineOfCreditMember2025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMembersbh:NailMember2025-10-012025-12-310001368458sbh:AccumulatedForeignExchangeContractsMember2025-10-012025-12-310001368458us-gaap:AdditionalPaidInCapitalMember2025-09-300001368458sbh:ShareRepurchaseProgram2017Member2017-08-310001368458sbh:SallyBeautySupplyMember2025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:StylingToolsAndSuppliesMembersbh:SallyMember2025-10-012025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMembersbh:SallyMemberus-gaap:EntityOperatedUnitsMember2025-10-012025-12-310001368458sbh:DentonTexasMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-10-012024-12-310001368458us-gaap:FairValueMeasurementsRecurringMember2025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:HairCareMember2025-10-012025-12-310001368458sbh:JohnGossMember2025-12-310001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-3000013684582024-12-310001368458us-gaap:InterestRateSwapMember2025-10-012025-12-310001368458us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherLiabilitiesMember2025-09-300001368458us-gaap:InterestRateSwapMember2025-12-310001368458us-gaap:FranchisedUnitsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMember2024-10-012024-12-310001368458us-gaap:FranchisedUnitsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMember2025-10-012025-12-31xbrli:puresbh:Segmentxbrli:sharessbh:Instrumentiso4217:USDxbrli:sharesiso4217:USD

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 10-Q

     

     

    ☒

    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    FOR THE QUARTERLY PERIOD ENDED: DECEMBER 31, 2025

    or

     

    ☐

    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    Commission File No. 1-33145

     

    SALLY BEAUTY HOLDINGS, INC.

    (Exact name of registrant as specified in its charter)

     

     

    Delaware

    36-2257936

    (State or other jurisdiction of incorporation or organization)

    (I.R.S. Employer Identification No.)

    7900 Windrose Ave

    Plano, Texas

    75024

    (Address of principal executive offices)

    (Zip Code)

     

    (800) 777-5706

    (Registrant’s telephone number, including area code)

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each class

    Trading Symbol

    Name of each exchange on which registered

    Common Stock, $0.01 par value

    SBH

    The New York Stock Exchange

     

    Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer

    ☒

     

    Accelerated filer

    ☐

    Non-accelerated filer

    ☐

    Smaller reporting company

    ☐

     

    Emerging growth company

    ☐

     

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

    Number of shares of common stock outstanding as of February 4, 2026: 97,008,814

     

     


     

    TABLE OF CONTENTS

     

    Page

    PART I — FINANCIAL INFORMATION

     

     

     

    Item 1. Financial Statements

    4

     

     

    Condensed Consolidated Balance Sheets

    4

    Condensed Consolidated Statements of Earnings

    5

    Condensed Consolidated Statements of Comprehensive Income

    6

    Condensed Consolidated Statements of Stockholders’ Equity

    7

    Condensed Consolidated Statements of Cash Flows

    8

    Notes to Condensed Consolidated Financial Statements

    9

     

     

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    16

    Item 3. Quantitative and Qualitative Disclosures About Market Risk

    21

    Item 4. Controls and Procedures

    21

     

    PART II — OTHER INFORMATION

     

     

     

    Item 1. Legal Proceedings

    22

    Item 1A. Risk Factors

    22

    Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities.

    22

    Item 5. Other Information

    22

    Item 6. Exhibits

    23

     

     

    2


     

    In this Quarterly Report, references to the “Company,” “our company,” “Sally Beauty,” “we,” “our,” “ours” and “us” refer to Sally Beauty Holdings, Inc. and its consolidated subsidiaries unless otherwise indicated or the context otherwise requires.

    cautionary notice regarding forward-looking statements

    Statements in this Quarterly Report on Form 10-Q and in the documents incorporated by reference herein which are not purely historical facts or which depend upon future events may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “project,” “target,” “can,” “could,” “may,” “should,” “will,” “would,” "might" or similar expressions may also identify such forward-looking statements.

    Readers are cautioned not to place undue reliance on forward-looking statements as such statements speak only as of the date they were made and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The most important factors which could cause our actual results to differ from our forward-looking statements are set forth in our description of risk factors in Item 1A contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025, which should be read in conjunction with the forward-looking statements in this report. Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update any forward-looking statement.

    The events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. As a result, our actual results may differ materially from the results contemplated by these forward-looking statements.

    3


     

    PART I — FINANCIAL INFORMATION

    Item 1. Financial Statements.

    SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

    Condensed Consolidated Balance Sheets

    (In thousands, except par value data)

     

     

     

    December 31,
    2025

     

     

    September 30,
    2025

     

     

     

    (Unaudited)

     

     

     

     

    Assets

     

     

     

     

     

     

    Current assets:

     

     

     

     

     

     

    Cash and cash equivalents

     

    $

    157,185

     

     

    $

    149,162

     

    Trade accounts receivable, net

     

     

    26,842

     

     

     

    31,828

     

    Accounts receivable, other

     

     

    77,425

     

     

     

    84,734

     

    Inventory

     

     

    978,789

     

     

     

    987,575

     

    Other current assets

     

     

    45,444

     

     

     

    48,154

     

    Total current assets

     

     

    1,285,685

     

     

     

    1,301,453

     

    Property and equipment, net of accumulated depreciation of $955,508 at
       December 31, 2025, and $
    937,596 at September 30, 2025

     

     

    280,350

     

     

     

    284,284

     

    Operating lease assets

     

     

    642,276

     

     

     

    646,698

     

    Goodwill

     

     

    541,524

     

     

     

    540,674

     

    Intangible assets, excluding goodwill, net of accumulated amortization of
       $
    15,384 at December 31, 2025, and $14,686 at September 30, 2025

     

     

    52,405

     

     

     

    53,018

     

    Other assets

     

     

    48,538

     

     

     

    44,969

     

    Total assets

     

    $

    2,850,778

     

     

    $

    2,871,096

     

    Liabilities and Stockholders’ Equity

     

     

     

     

     

     

    Current liabilities:

     

     

     

     

     

     

    Current maturities of long-term debt

     

    $

    4,000

     

     

    $

    4,000

     

    Accounts payable

     

     

    208,481

     

     

     

    224,507

     

    Accrued liabilities

     

     

    158,576

     

     

     

    184,641

     

    Current operating lease liabilities

     

     

    157,102

     

     

     

    158,566

     

    Income taxes payable

     

     

    14,011

     

     

     

    4,260

     

    Total current liabilities

     

     

    542,170

     

     

     

    575,974

     

    Long-term debt

     

     

    842,531

     

     

     

    861,974

     

    Long-term operating lease liabilities

     

     

    537,594

     

     

     

    538,426

     

    Other liabilities

     

     

    21,985

     

     

     

    21,026

     

    Deferred income tax liabilities, net

     

     

    82,933

     

     

     

    79,489

     

    Total liabilities

     

     

    2,027,213

     

     

     

    2,076,889

     

    Stockholders’ equity:

     

     

     

     

     

     

    Common stock, $0.01 par value. Authorized 500,000 shares; 97,492 and
       
    97,875 shares issued and shares outstanding at December 31, 2025, and
       September 30, 2025, respectively

     

     

    975

     

     

     

    979

     

    Preferred stock, $0.01 par value. Authorized 50,000 shares; none issued

     

     

    —

     

     

     

    —

     

    Accumulated earnings

     

     

    923,306

     

     

     

    898,076

     

    Accumulated other comprehensive loss, net of tax

     

     

    (100,716

    )

     

     

    (104,848

    )

    Total stockholders’ equity

     

     

    823,565

     

     

     

    794,207

     

    Total liabilities and stockholders’ equity

     

    $

    2,850,778

     

     

    $

    2,871,096

     

     

    The accompanying notes are an integral part of these condensed consolidated financial statements.

    4


     

    SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

    Condensed Consolidated Statements of Earnings

    (In thousands, except per share data)

    (Unaudited)

     

     

     

    Three Months Ended

     

     

     

    December 31,

     

     

     

    2025

     

     

    2024

     

    Net sales

     

    $

    943,168

     

     

    $

    937,895

     

    Cost of goods sold

     

     

    459,909

     

     

     

    461,055

     

    Gross profit

     

     

    483,259

     

     

     

    476,840

     

    Selling, general and administrative expenses

     

     

    407,324

     

     

     

    376,520

     

    Operating earnings

     

     

    75,935

     

     

     

    100,320

     

    Interest expense

     

     

    14,620

     

     

     

    17,442

     

    Earnings before provision for income taxes

     

     

    61,315

     

     

     

    82,878

     

    Provision for income taxes

     

     

    15,758

     

     

     

    21,865

     

    Net earnings

     

    $

    45,557

     

     

    $

    61,013

     

    Earnings per share:

     

     

     

     

     

     

    Basic

     

    $

    0.47

     

     

    $

    0.60

     

    Diluted

     

    $

    0.45

     

     

    $

    0.58

     

    Weighted-average shares:

     

     

     

     

     

     

    Basic

     

     

    97,804

     

     

     

    102,021

     

    Diluted

     

     

    100,765

     

     

     

    104,974

     

     

     

    The accompanying notes are an integral part of these condensed consolidated financial statements.

    5


     

    SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

    Condensed Consolidated Statements of Comprehensive Income

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended

     

     

     

    December 31,

     

     

     

    2025

     

     

    2024

     

    Net earnings

     

    $

    45,557

     

     

    $

    61,013

     

    Other comprehensive income (loss):

     

     

     

     

     

     

    Foreign currency translation adjustments

     

     

    4,387

     

     

     

    (26,615

    )

    Interest rate swap, net of tax

     

     

    (139

    )

     

     

    1,151

     

    Foreign exchange contracts, net of tax

     

     

    (116

    )

     

     

    1,483

     

    Other comprehensive income (loss), net of tax

     

     

    4,132

     

     

     

    (23,981

    )

    Total comprehensive income

     

    $

    49,689

     

     

    $

    37,032

     

     

     

    The accompanying notes are an integral part of these condensed consolidated financial statements.

    6


     

    SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

    Condensed Consolidated Statements of Stockholders’ Equity

    (In thousands)

    (Unaudited)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Accumulated

     

     

     

     

     

     

     

     

     

     

     

    Additional

     

     

     

     

     

    Other

     

     

    Total

     

     

    Common Stock

    Paid-in

     

     

    Accumulated

     

     

    Comprehensive

     

     

    Stockholders’

     

     

    Shares

     

     

    Amount

     

     

    Capital

     

     

    Earnings

     

     

    Loss

     

     

    Equity

     

    Balance at September 30, 2025

     

    97,875

     

     

    $

    979

     

     

    $

    —

     

     

    $

    898,076

     

     

    $

    (104,848

    )

     

    $

    794,207

     

    Net earnings

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    45,557

     

     

     

    —

     

     

     

    45,557

     

    Other comprehensive income

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    4,132

     

     

     

    4,132

     

    Share-based compensation

     

    —

     

     

     

    —

     

     

     

    7,555

     

     

     

    —

     

     

     

    —

     

     

     

    7,555

     

    Stock issued for equity awards

     

    1,493

     

     

     

    15

     

     

     

    192

     

     

     

    —

     

     

     

    —

     

     

     

    207

     

    Employee withholding taxes paid
       related to net share settlement

     

    (517

    )

     

     

    (5

    )

     

     

    (7,331

    )

     

     

    —

     

     

     

    —

     

     

     

    (7,336

    )

    Repurchases and cancellations of
       common stock

     

    (1,359

    )

     

     

    (14

    )

     

     

    (416

    )

     

     

    (20,327

    )

     

     

    —

     

     

     

    (20,757

    )

    Balance at December 31, 2025

     

    97,492

     

     

    $

    975

     

     

    $

    —

     

     

    $

    923,306

     

     

    $

    (100,716

    )

     

    $

    823,565

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Accumulated

     

     

     

     

     

     

     

     

     

     

     

    Additional

     

     

     

     

     

    Other

     

     

    Total

     

     

    Common Stock

    Paid-in

     

     

    Accumulated

     

     

    Comprehensive

     

     

    Stockholders’

     

     

    Shares

     

     

    Amount

     

     

    Capital

     

     

    Earnings

     

     

    Loss

     

     

    Equity

     

    Balance at September 30, 2024

     

    101,854

     

     

    $

    1,019

     

     

    $

    —

     

     

    $

    740,685

     

     

    $

    (113,169

    )

     

    $

    628,535

     

    Net earnings

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    61,013

     

     

     

    —

     

     

     

    61,013

     

    Other comprehensive loss

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (23,981

    )

     

     

    (23,981

    )

    Share-based compensation

     

    —

     

     

     

    —

     

     

     

    6,053

     

     

     

    —

     

     

     

    —

     

     

     

    6,053

     

    Stock issued for equity awards

     

    1,162

     

     

     

    12

     

     

     

    69

     

     

     

    —

     

     

     

    —

     

     

     

    81

     

    Employee withholding taxes paid
       related to net share settlement

     

    (392

    )

     

     

    (4

    )

     

     

    (5,260

    )

     

     

    —

     

     

     

    —

     

     

     

    (5,264

    )

    Repurchases and cancellations of
       common stock

     

    (753

    )

     

     

    (8

    )

     

     

    (862

    )

     

     

    (9,078

    )

     

     

    —

     

     

     

    (9,948

    )

    Balance at December 31, 2024

     

    101,871

     

     

    $

    1,019

     

     

    $

    —

     

     

    $

    792,620

     

     

    $

    (137,150

    )

     

    $

    656,489

     

     

    The accompanying notes are an integral part of these condensed consolidated financial statements.

    7


     

    SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

    Condensed Consolidated Statements of Cash Flows

    (In thousands)

    (Unaudited)

     

     

     

    Three Months Ended December 31,

     

     

     

    2025

     

     

    2024

     

    Cash Flows from Operating Activities:

     

     

     

     

     

     

    Net earnings

     

    $

    45,557

     

     

    $

    61,013

     

    Adjustments to reconcile net earnings to net cash provided
        by operating activities:

     

     

     

     

     

     

    Depreciation and amortization

     

     

    23,632

     

     

     

    25,565

     

    Share-based compensation expense

     

     

    7,555

     

     

     

    6,053

     

    Amortization of deferred financing costs

     

     

    477

     

     

     

    564

     

    Loss on early extinguishment of debt

     

     

    159

     

     

     

    444

     

    Loss (gain) on disposal of equipment and other property

     

     

    11

     

     

     

    (26,641

    )

    Deferred income taxes

     

     

    3,021

     

     

     

    (2,207

    )

    Changes in (exclusive of effects of acquisitions):

     

     

     

     

     

     

    Trade accounts receivable

     

     

    5,120

     

     

     

    6,269

     

    Accounts receivable, other

     

     

    7,429

     

     

     

    (799

    )

    Inventory

     

     

    13,593

     

     

     

    15,287

     

    Other current assets

     

     

    2,815

     

     

     

    1,454

     

    Other assets

     

     

    (3,238

    )

     

     

    1,578

     

    Operating leases, net

     

     

    2,097

     

     

     

    (939

    )

    Accounts payable and accrued liabilities

     

     

    (25,699

    )

     

     

    (56,152

    )

    Income taxes payable

     

     

    9,750

     

     

     

    2,225

     

    Other liabilities

     

     

    960

     

     

     

    (257

    )

    Net cash provided by operating activities

     

     

    93,239

     

     

     

    33,457

     

    Cash Flows from Investing Activities:

     

     

     

     

     

     

    Payments for property and equipment

     

     

    (35,784

    )

     

     

    (20,078

    )

    Proceeds from sale of property and equipment, net

     

     

    —

     

     

     

    43,574

     

    Acquisitions, net of cash acquired

     

     

    —

     

     

     

    (371

    )

    Net cash (used) provided by investing activities

     

     

    (35,784

    )

     

     

    23,125

     

    Cash Flows from Financing Activities:

     

     

     

     

     

     

    Proceeds from issuance of long-term debt and ABL Facility

     

     

    —

     

     

     

    112,000

     

    Repayments of long-term debt and ABL Facility

     

     

    (20,000

    )

     

     

    (153,041

    )

    Debt issuance costs

     

     

    —

     

     

     

    (1,495

    )

    Proceeds from equity awards

     

     

    207

     

     

     

    81

     

    Payments for common stock repurchased

     

     

    (20,757

    )

     

     

    (9,948

    )

    Employee withholding taxes paid related to net share settlement of equity awards

     

     

    (7,336

    )

     

     

    (5,264

    )

    Net cash used by financing activities

     

     

    (47,886

    )

     

     

    (57,667

    )

    Effect of foreign exchange rate changes on cash and cash equivalents

     

     

    (1,546

    )

     

     

    (1,348

    )

    Net increase (decrease) in cash and cash equivalents

     

     

    8,023

     

     

     

    (2,433

    )

    Cash and cash equivalents, beginning of period

     

     

    149,162

     

     

     

    107,961

     

    Cash and cash equivalents, end of period

     

    $

    157,185

     

     

    $

    105,528

     

    Supplemental Cash Flow Information:

     

     

     

     

     

     

    Interest paid

     

    $

    4,442

     

     

    $

    7,648

     

    Income taxes paid

     

    $

    2,575

     

     

    $

    19,264

     

    Capital expenditures incurred but not paid

     

    $

    6,883

     

     

    $

    8,135

     

     

     

    The accompanying notes are an integral part of these condensed consolidated financial statements.

    8


     

    Sally Beauty Holdings, Inc. and Subsidiaries

    Notes to Condensed Consolidated Financial Statements

    (Unaudited)

    1. Significant Accounting Policies

    Basis of Presentation

    The unaudited condensed consolidated interim financial statements of Sally Beauty Holdings, Inc. and its subsidiaries included herein have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and pursuant to the rules and regulations of the Security and Exchange Commission ("SEC"). Accordingly, certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted, although we believe that the disclosures included herein are adequate for the interim period presented. These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025. In the opinion of management, these unaudited condensed consolidated interim financial statements reflect all adjustments that are of a normal recurring nature and that are necessary to present fairly our consolidated financial position as of December 31, 2025, and September 30, 2025, our consolidated results of operations, consolidated comprehensive income, consolidated statements of stockholders’ equity, and consolidated cash flows for the three months ended December 31, 2025 and 2024.

    Principles of Consolidation

    The unaudited condensed consolidated interim financial statements include all accounts of Sally Beauty Holdings, Inc. and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. All amounts are presented in U.S. Dollars.

    Accounting Policies

    We adhere to the same accounting policies in the preparation of our condensed consolidated interim financial statements as we do in the preparation of our full year consolidated financial statements. As permitted under GAAP, interim accounting for certain expenses, including income taxes, is based on full-year assumptions. For interim financial reporting purposes, income taxes are recorded based upon our estimated annual effective income tax.

    Use of Estimates

    In order to present our unaudited condensed consolidated interim financial statements in conformity with GAAP, we are required to make certain estimates and assumptions that impact our interim financial statements and supplementary disclosures. These estimates may use forecasted financial information based on reasonable assumptions available at the time of preparation, however, actual results could differ due to changes in facts and circumstances. Significant estimates and assumptions are involved in the accounting for sales allowances, deferred revenue, valuation of inventory, amortization and depreciation, intangible assets and goodwill, and other reserves. We believe these estimates and assumptions are reasonable based on management’s knowledge of current events and anticipated further actions, and changes in facts and circumstances may result in revised estimates and impact actual results. Revisions to estimates are recognized in the period in which the facts that give rise to the change become known.

    2. Recent Accounting Pronouncements

    In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to expand disclosures in an entity’s income tax rate reconciliation table and the disaggregation of taxes paid in U.S. and foreign jurisdictions. The amendments in this update are effective for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this update, but we do not expect the update to impact our consolidated results of operations or financial position.

    In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income: Expense Disaggregation Disclosures (Subtopic 220-40), which requires, among other things, more detailed disclosure about types of expenses in commonly presented expense captions such as cost of goods sold and selling, general and administrative expenses. The update is intended to improve disclosures by providing amounts related to inventory purchases, employee compensation, depreciation, and amortization. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal

    9


     

    years beginning after December 15, 2027. Early adoption is permitted, but we currently do not expect to early adopt this standard. We are currently evaluating the impact of this update to our consolidated financial statements and disclosures.

    3. Revenue Recognition

    Substantially all of our revenue is derived through the sale of merchandise at the point-of-sale in our stores or when products are shipped for e-commerce orders. Revenue is recognized net of estimated sales returns and sales taxes, when control of the merchandise is transferred to the customer. We estimate sales returns based on historical data.

    Changes to our contract liabilities, which are included in accrued liabilities in our condensed consolidated balance sheets, were as follows (in thousands):

     

     

     

     

     

     

    Three Months Ended December 31,

     

     

     

     

     

     

     

    2025

     

     

    2024

     

    Beginning Balance

     

     

     

     

     

    $

    10,027

     

     

    $

    11,493

     

    Loyalty points and gift cards issued but not redeemed, net of estimated breakage

     

     

    3,424

     

     

     

    3,644

     

    Revenue recognized from beginning liability

     

     

    (2,415

    )

     

     

    (2,487

    )

    Ending Balance

     

     

     

     

     

    $

    11,036

     

     

    $

    12,650

     

    See Note 12, Segment Reporting, for additional information regarding the disaggregation of our sales revenue.

     

    4. Fair Value Measurements

    We measure on a recurring basis and disclose the fair value of our financial instruments under the provisions of ASC Topic 820, Fair Value Measurement, as amended (“ASC 820”). We define “fair value” as the price that would be received to sell an asset or paid to transfer a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-level hierarchy for measuring fair value and requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. This valuation hierarchy is based upon the transparency of inputs used in the valuation of an asset or liability on the measurement date.

    The three levels of that hierarchy are defined as follows:

    Level 1 - Quoted prices are available in active markets for identical assets or liabilities;

    Level 2 - Pricing inputs are other than quoted prices in active markets, included in Level 1, that are either directly or indirectly observable; and

    Level 3 - Unobservable pricing inputs in which little or no market activity exists, therefore requiring an entity to develop its own model with estimates and assumptions.

    Financial instruments measured at fair value on recurring basis

    Consistent with the fair value hierarchy, we categorized our financial assets and liabilities as follows:

    (in thousands)

     

    Classification

     

    Fair Value Hierarchy Level

     

    December 31,
    2025

     

     

    September 30,
    2025

     

    Financial Assets:

     

     

     

     

     

     

     

     

     

     

    Foreign exchange contracts

     

     

     

     

     

     

     

     

     

     

    Designated cash flow hedges

     

     Other current assets

     

    Level 2

     

    $

    22

     

     

    $

    87

     

    Non-designated cash flow hedges

     

     Other current assets

     

    Level 2

     

     

    13

     

     

     

    570

     

    Interest rate swap

     

     Other assets

     

    Level 2

     

     

    —

     

     

     

    59

     

    Total assets

     

     

     

     

     

    $

    35

     

     

    $

    716

     

    .

     

     

     

     

     

     

     

     

     

     

    Financial Liabilities:

     

     

     

     

     

     

     

     

     

     

    Foreign exchange contracts

     

     

     

     

     

     

     

     

     

     

    Designated cash flow hedges

     

     Accrued liabilities

     

    Level 2

     

    $

    482

     

     

    $

    57

     

    Non-designated cash flow hedges

     

     Accrued liabilities

     

    Level 2

     

     

    250

     

     

     

    225

     

    Interest rate swap

     

     Other Liabilities

     

    Level 2

     

     

    52

     

     

     

    —

     

    Total liabilities

     

     

     

     

     

    $

    784

     

     

    $

    282

     

    The fair value of each asset and liability was determined using widely accepted valuation techniques, including discounted cash flow analyses and observable inputs, such as market interest rates and foreign exchange rates.

    10


     

    Other fair value disclosures

    The carrying amounts, if any, of cash equivalents, trade and other accounts receivable, accounts payable, and borrowings under our $500 million asset-based senior secured loan facility (the “ABL Facility”) approximate their respective fair values due to the short-term nature of these financial instruments. The carrying amounts and corresponding estimated fair values of our long-term debt, excluding debt issuance costs and original issue discounts, are as follows:

     

     

    Fair Value

     

    December 31, 2025

     

     

    September 30, 2025

     

    (in thousands)

     

    Hierarchy Level

     

    Carrying Value

     

     

    Fair Value

     

     

    Carrying Value

     

     

    Fair Value

     

    Long-term debt

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Senior notes due 2032

     

    Level 2

     

    $

    600,000

     

     

    $

    625,500

     

     

    $

    600,000

     

     

    $

    622,500

     

    Term loan B due 2030

     

    Level 2

     

     

    255,000

     

     

     

    256,275

     

     

     

    275,000

     

     

     

    276,375

     

    Total long-term debt

     

     

     

    $

    855,000

     

     

    $

    881,775

     

     

    $

    875,000

     

     

    $

    898,875

     

     

    The fair value of our senior notes was determined using unadjusted quoted market prices. The fair value of our Term Loan B agreement was determined using unadjusted quoted market prices for similar debt securities in active markets.

    5. Stockholders’ Equity

    Share Repurchases

    In August 2017, our Board of Directors (the “Board”) approved a share repurchase program authorizing us to repurchase up to $1.0 billion of our common stock, subject to certain limitations governed by our debt agreements. In May 2025, our Board approved a term extension of our share repurchase program to September 30, 2029. Under this extension the Company is authorized to purchase its common stock up to the amount remaining under the Board’s 2017 authorization. As of December 31, 2025, we had approximately $446.6 million of additional share repurchase authorizations remaining under our share repurchase program. For the three months ended December 31, 2025 and 2024, we repurchased 1.4 million shares and 0.8 million shares of our common stock at a total cost of $20.7 million and $10.0 million, respectively, excluding the impact of excise taxes.

    Accumulated Other Comprehensive Loss

    The change in accumulated other comprehensive loss (“AOCL”) was as follows (in thousands):

     

     

    Foreign Currency Translation Adjustments

     

     

    Interest Rate Swap

     

     

    Foreign Exchange Contracts

     

     

    Total

     

     

    Balance at September 30, 2025

     

    $

    (104,329

    )

     

    $

    84

     

     

    $

    (603

    )

     

    $

    (104,848

    )

     

    Other comprehensive income (loss) before
        reclassification, net of tax

     

     

    4,387

     

     

     

    (23

    )

     

     

    (387

    )

     

     

    3,977

     

     

    Reclassification to net earnings, net of tax

     

     

    —

     

     

     

    (116

    )

     

     

    271

     

     

     

    155

     

     

    Balance at December 31, 2025

     

    $

    (99,942

    )

     

    $

    (55

    )

     

    $

    (719

    )

     

    $

    (100,716

    )

     

    The tax impacts for the changes in other comprehensive income (loss) and the reclassifications to net earnings were not material.

    6. Weighted-Average Shares

    The following table presents a reconciliation of basic and diluted weighted-average shares (in thousands):

     

     

    Three Months Ended
    December 31,

     

     

     

    2025

     

     

    2024

     

    Weighted-average basic shares

     

     

    97,804

     

     

     

    102,021

     

    Dilutive securities:

     

     

     

     

     

     

    Stock option and stock award programs

     

     

    2,961

     

     

     

    2,953

     

    Weighted-average diluted shares

     

     

    100,765

     

     

     

    104,974

     

     

     

     

     

     

     

     

    Anti-dilutive options excluded from our computation of diluted shares

     

     

    1,272

     

     

     

    1,522

     

     

    11


     

    7. Property and Equipment, Net

    During the three months ended December 31, 2024, we sold our corporate headquarters located in Denton, Texas to Denton County, Texas for $45.5 million, excluding $1.5 million in closing costs. As a result of the sale, we recognized a gain of approximately $26.6 million within selling, general and administrative expenses in our condensed consolidated statements of earnings.

    8. Goodwill and Intangible Assets

    For the three months ended December 31, 2025, we considered potential triggering events and determined that there were none during the period. No material impairment losses were recognized in the current or prior periods presented in connection with our goodwill and other intangible assets.

    Goodwill allocated to our Sally and BSG reporting units, which are also defined as our Sally and BSG segments, was $91.7 million and $449.8 million, respectively, as of December 31, 2025. For the three months ended December 31, 2025, changes in goodwill reflect the effects of foreign currency exchange rates of $0.9 million.

     

    The following table presents our amortization expense for the period (in thousands):

     

     

     

    Three Months Ended
    December 31,

     

     

     

    2025

     

     

    2024

     

    Intangible assets amortization expense

     

    $

    652

     

     

    $

    858

     

     

    9. Accrued Liabilities

    Accrued liabilities consist of the following (in thousands):

     

     

    December 31,
    2025

     

     

    September 30,
    2025

     

    Compensation and benefits

     

    $

    55,519

     

     

    $

    85,058

     

    Deferred revenue

     

     

    15,619

     

     

     

    14,195

     

    Interest payable

     

     

    13,917

     

     

     

    3,819

     

    Rental obligations

     

     

    11,405

     

     

     

    10,286

     

    Insurance reserves

     

     

    7,525

     

     

     

    7,331

     

    Accrued freight

     

     

    7,496

     

     

     

    8,761

     

    Operating accruals and other

     

     

    47,095

     

     

     

    55,191

     

    Total accrued liabilities

     

    $

    158,576

     

     

    $

    184,641

     

     

     

     

     

     

     

     

     

    10. Short-term and Long-term Debt

    At December 31, 2025, there were no outstanding borrowings under our ABL Facility, and we had $482.4 million available for borrowing, including under our Canadian sub-facility, subject to a borrowing base limitation, as reduced by outstanding letters of credit.

    During the three months ended December 31, 2025, we voluntarily repaid $19.0 million of outstanding Term Loan B principal in addition to our mandatory quarterly payment. In connection with the voluntary repayment, we recognized a $0.2 million loss on debt extinguishment within interest expense related to unamortized debt issuance costs for the three months ended December 31, 2025.

     

    11. Derivative Instruments and Hedging Activities

    During the three months ended December 31, 2025, we did not purchase or hold any derivative instruments for trading or speculative purposes. See Note 4, Fair Value Measurements, for the classification and fair value of our derivative instruments.

    Designated Cash Flow Hedges

    Foreign Currency Forwards

    We regularly enter into foreign currency forwards to mitigate our exposure to exchange rate changes on forecasted inventory purchases in U.S. dollars by our foreign subsidiaries. At December 31, 2025, we held forwards, which expire ratably through September 30, 2026, with a notional amount, based upon exchange rates at December 31, 2025, as follows (in thousands):

    12


     

    Notional Currency

     

    Notional Amount

     

    Mexican Peso

     

    $

    13,507

     

    Canadian Dollar

     

     

    6,799

     

    Euro

     

     

    2,487

     

    Total

     

    $

    22,793

     

     

    The changes in fair value related to these foreign currency forwards are recorded quarterly into AOCL. As the forwards are exercised, the realized gains or losses are recognized into cost of goods sold (“COGS”), based on inventory turns, in our condensed consolidated statements of earnings. For the three months ended December 31, 2025 and 2024, we recognized losses of $0.3 million and $0.2 million, respectively. Based on December 31, 2025, valuations and exchange rates, we expect to reclassify losses of approximately $0.6 million out of AOCL and into COGS over the next 12 months.

    Interest Rate Swap

    In April 2023, we entered into a three-year interest rate swap agreement with an initial notional amount of $200 million (the “Interest Rate Swap”) to mitigate the exposure to higher interest rates in connection with our Term Loan B due in 2030. The Interest Rate Swap involves fixed monthly payments at the contract rate of 3.705%, and in return, we will receive a floating interest payment based on the 1-month Adjusted Term SOFR Rate. The Interest Rate Swap will mature in April 2026 and is designated as a cash flow hedge. Changes in the fair value of the Interest Rate Swap are recorded quarterly, net of income tax, and included in AOCL.

    Each month, we recognize either income or expense, based on the position of the interest rates, into interest expense on our condensed consolidated statements of earnings related to the Interest Rate Swap. For the three months ended December 31, 2025, we recognized income of $0.2 million and $0.5 million, respectively. At December 31, 2025, we expect to reclassify a net loss of approximately $0.1 million out of AOCL and into interest expense over the next 12 months.

    Non-Designated Derivative Instruments

    We also use foreign exchange forward contracts to mitigate our exposure to exchange rate fluctuations related to certain intercompany balances that are not considered permanently invested. At December 31, 2025, we held forward contracts, which mature at various dates during the first month of each of the next two fiscal quarters, with a notional amount, based upon exchange rates at December 31, 2025, as follows (in thousands):

    Notional Currency

     

    Notional Amount

     

    British Pound

     

    $

    48,916

     

    Euro

     

     

    18,021

     

    Canadian Dollar

     

     

    11,465

     

    Mexican Peso

     

     

    3,423

     

    Total

     

    $

    81,825

     

    Changes in the fair value of the forward contracts, as well as realized gains or losses upon settlement, are recorded in selling, general and administrative expenses. For the three months ended December 31, 2025 and 2024, the effects of these foreign exchange contracts on our condensed consolidated financial statements were a net loss of $0.3 million and a net gain of $1.6 million, respectively.

     

     

    12. Segment Reporting

    Our business is organized into two reportable segments: (i) Sally, a domestic and international chain of retail stores and digital platforms that offers professional beauty supplies to both salon professionals and retail customers primarily in North America, including Puerto Rico, and parts of Europe and South America and, (ii) BSG, including its franchise-based business Armstrong McCall, a full service distributor of beauty products and supplies that offers professional beauty products directly to salons and salon professionals through its professional-only stores, its own sales force, and digital platforms in partially exclusive geographical territories in the U.S., including Puerto Rico, and Canada.

    Our Chief Operating Decision Maker ("CODM"), whom we have determined to be our Chief Executive Officer, regularly evaluates the performance of our reportable segments by comparing current segment operating earnings to comparable prior periods and forecasted amounts. Included within segment operating earnings, the significant expense categories below are regularly provided to the CODM.

    13


     

    Segment Operating Performance

    The following tables summarize our results:

    `

     

    Three Months Ended December 31, 2025

     

    (in thousands)

     

    Sally

     

     

    BSG

     

     

    Total

     

    Net sales (a)

     

    $

    531,601

     

     

    $

    411,567

     

     

    $

    943,168

     

    Less: (b)

     

     

     

     

     

     

     

     

     

    Cost of goods sold

     

     

    213,659

     

     

     

    246,250

     

     

     

    459,909

     

    Selling, general, and administrative expenses

     

     

    240,045

     

     

     

    111,410

     

     

     

    351,455

     

    Segment operating earnings

     

     

    77,897

     

     

     

    53,907

     

     

     

    131,804

     

     

     

     

     

     

     

     

     

     

     

    Unallocated expenses (c)

     

     

     

     

     

     

     

     

    55,869

     

    Interest expense

     

     

     

     

     

     

     

     

    14,620

     

    Earnings before provision for income taxes

     

     

     

     

     

     

     

    $

    61,315

     

     

     

    `

     

    Three Months Ended December 31, 2024

     

    (in thousands)

     

    Sally

     

     

    BSG

     

     

    Total

     

    Net sales (a)

     

    $

    525,446

     

     

    $

    412,449

     

     

    $

    937,895

     

    Less: (b)

     

     

     

     

     

     

     

     

     

    Cost of goods sold

     

     

    212,191

     

     

     

    248,864

     

     

     

    461,055

     

    Selling, general, and administrative expenses

     

     

    233,381

     

     

     

    113,116

     

     

     

    346,497

     

    Segment operating earnings

     

     

    79,874

     

     

     

    50,469

     

     

     

    130,343

     

     

     

     

     

     

     

     

     

     

     

    Unallocated expenses (c)

     

     

     

     

     

     

     

     

    30,023

     

    Interest expense

     

     

     

     

     

     

     

     

    17,442

     

    Earnings before provision for income taxes

     

     

     

     

     

     

     

    $

    82,878

     

     

    (a)
    There were no intersegment sales between our segments, nor did any single customer account for 10% or more of revenue.
    (b)
    The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
    (c)
    Unallocated expenses consist of corporate and shared costs and are included in selling, general and administrative expenses in our condensed consolidated statements of earnings. For the three months ended December 31, 2024, unallocated expenses included a $26.6 million gain related to the sale of our corporate headquarters. See Note 7, Property and Equipment, Net, for more information.


    Other Segment Disclosures

     

     

     

    Three Months Ended December 31,

     

    (in thousands)

     

    2025

     

     

    2024

     

    Depreciation and amortization:

     

     

     

     

     

     

    Sally

     

    $

    13,432

     

     

    $

    14,658

     

    BSG

     

     

    8,673

     

     

     

    8,487

     

    Unallocated

     

     

    1,527

     

     

     

    2,420

     

    Total

     

    $

    23,632

     

     

    $

    25,565

     

     

     

     

     

     

     

     

     

    14


     

    Disaggregation of net sales by segment

    The following tables disaggregate our segment revenues by merchandise category.

     

     

    Three Months Ended December 31,

     

    Sally

     

    2025

     

     

    2024

     

    Hair color

     

     

    43.0

    %

     

     

    40.5

    %

    Hair care

     

     

    22.2

    %

     

     

    23.8

    %

    Styling tools and supplies

     

     

    17.3

    %

     

     

    17.3

    %

    Nail

     

     

    9.9

    %

     

     

    10.1

    %

    Skin and cosmetics

     

     

    7.4

    %

     

     

    7.7

    %

    Other beauty items

     

     

    0.2

    %

     

     

    0.6

    %

    Total

     

     

    100.0

    %

     

     

    100.0

    %

     

     

     

    Three Months Ended December 31,

     

    BSG

     

    2025

     

     

    2024

     

    Hair care

     

     

    42.7

    %

     

     

    42.8

    %

    Hair color

     

     

    41.6

    %

     

     

    40.1

    %

    Styling tools and supplies

     

     

    10.1

    %

     

     

    10.7

    %

    Skin and cosmetics

     

     

    3.4

    %

     

     

    3.8

    %

    Nail

     

     

    2.0

    %

     

     

    2.4

    %

    Other beauty items

     

     

    0.2

    %

     

     

    0.2

    %

    Total

     

     

    100.0

    %

     

     

    100.0

    %

    The following tables disaggregate our segment revenue by sales channels:

     

     

    Three Months Ended December 31,

     

    Sally

     

    2025

     

     

    2024

     

    Company-operated stores

     

     

    90.5

    %

     

     

    92.1

    %

    E-commerce

     

     

    9.5

    %

     

     

    7.9

    %

    Total

     

     

    100.0

    %

     

     

    100.0

    %

     

     

     

    Three Months Ended December 31,

     

    BSG

     

    2025

     

     

    2024

     

    Company-operated stores

     

     

    69.2

    %

     

     

    69.4

    %

    E-commerce

     

     

    14.6

    %

     

     

    14.0

    %

    Salon business consultants

     

     

    8.6

    %

     

     

    9.6

    %

    Franchise stores

     

     

    7.6

    %

     

     

    7.0

    %

    Total

     

     

    100.0

    %

     

     

    100.0

    %

     

     

    15


     

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    This section discusses management’s view of the financial condition, results of operations and cash flows of Sally Beauty for the periods covered by this Quarterly Report. This section should be read in conjunction with the information contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025, including the Risk Factors sections therein, and information contained elsewhere in this Quarterly Report, including the condensed consolidated interim financial statements and notes to those financial statements.

    Financial Summary for the Three Months Ended December 31, 2025

    •
    Consolidated net sales for the three months ended December 31, 2025, increased $5.3 million, or 0.6%, to $943.2 million, compared to the three months ended December 31, 2024. Consolidated net sales included a positive impact from changes in foreign currency exchange rates of $8.5 million;
    •
    Consolidated comparable sales were flat for the three months ended December 31, 2025;
    •
    Consolidated gross profit for the three months ended December 31, 2025, increased $6.4 million, or 1.3%, to $483.3 million, compared to the three months ended December 31, 2024. Consolidated gross margin increased 40 bps to 51.2% for the three months ended December 31, 2025, compared to the three months ended December 31, 2024;
    •
    Consolidated operating earnings for the three months ended December 31, 2025, decreased $24.4 million, or 24.3%, to $75.9 million, compared to the three months ended December 31, 2024. Operating margin decreased 260 bps to 8.1% for the three months ended December 31, 2025, compared to the three months ended December 31, 2024;
    •
    For the three months ended December 31, 2025, our consolidated net earnings decreased $15.5 million, or 25.3%, to $45.6 million, compared to the three months ended December 31, 2024;
    •
    For the three months ended December 31, 2025, our diluted earnings per share was $0.45 compared to $0.58 for the three months ended December 31, 2024; and
    •
    Cash provided by operations was $93.2 million for the three months ended December 31, 2025, compared to $33.5 million for the three months ended December 31, 2024.

    Comparable Sales

    We believe that comparable sales is an appropriate performance indicator to measure our sales growth compared to the prior period. Our comparable sales include sales from stores that have been operating for 14 months or longer as of the last day of a month and from e-commerce revenue. Additionally, comparable sales include sales to franchisees and full service sales. Our comparable sales excludes the effect of changes in foreign exchange rates and sales from stores relocated until 14 months after the relocation. Revenue from acquired stores is excluded from our comparable sales calculation until 14 months after the acquisition. Our calculation of comparable sales might not be the same as other retailers as the calculation varies across the retail industry.

    16


     

    Overview

    Key Operating Metrics

    The following table sets forth, for the periods indicated, information concerning key measures on which we rely to evaluate our operating performance (dollars in thousands):

     

     

    Three Months Ended December 31,

     

     

     

    2025

     

     

    2024

     

     

    Increase (Decrease)

     

    Net sales:

     

     

     

     

     

     

     

     

     

     

     

     

    Sally

     

    $

    531,601

     

     

    $

    525,446

     

     

    $

    6,155

     

     

     

    1.2

    %

    BSG

     

     

    411,567

     

     

     

    412,449

     

     

     

    (882

    )

     

     

    (0.2

    )%

    Consolidated

     

    $

    943,168

     

     

    $

    937,895

     

     

    $

    5,273

     

     

     

    0.6

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Gross profit:

     

     

     

     

     

     

     

     

     

     

     

     

    Sally

     

    $

    317,942

     

     

    $

    313,255

     

     

    $

    4,687

     

     

     

    1.5

    %

    BSG

     

     

    165,317

     

     

     

    163,585

     

     

     

    1,732

     

     

     

    1.1

    %

    Consolidated

     

    $

    483,259

     

     

    $

    476,840

     

     

    $

    6,419

     

     

     

    1.3

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Segment gross margin:

     

     

     

     

     

     

     

     

     

     

     

     

    Sally

     

     

    59.8

    %

     

     

    59.6

    %

     

    20

     

     

     bps

     

    BSG

     

     

    40.2

    %

     

     

    39.7

    %

     

    50

     

     

     bps

     

    Consolidated

     

     

    51.2

    %

     

     

    50.8

    %

     

    40

     

     

     bps

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net earnings:

     

     

     

     

     

     

     

     

     

     

     

     

    Segment operating earnings:

     

     

     

     

     

     

     

     

     

     

     

     

    Sally

     

    $

    77,897

     

     

    $

    79,874

     

     

    $

    (1,977

    )

     

     

    (2.5

    )%

    BSG

     

     

    53,907

     

     

     

    50,469

     

     

     

    3,438

     

     

     

    6.8

    %

    Segment operating earnings

     

     

    131,804

     

     

     

    130,343

     

     

     

    1,461

     

     

     

    1.1

    %

    Unallocated expenses (a)

     

     

    55,869

     

     

     

    30,023

     

     

     

    25,846

     

     

     

    86.1

    %

    Consolidated operating earnings

     

     

    75,935

     

     

     

    100,320

     

     

     

    (24,385

    )

     

     

    (24.3

    )%

    Interest expense

     

     

    14,620

     

     

     

    17,442

     

     

     

    (2,822

    )

     

     

    (16.2

    )%

    Earnings before provision for income taxes

     

     

    61,315

     

     

     

    82,878

     

     

     

    (21,563

    )

     

     

    (26.0

    )%

    Provision for income taxes

     

     

    15,758

     

     

     

    21,865

     

     

     

    (6,107

    )

     

     

    (27.9

    )%

    Net earnings

     

    $

    45,557

     

     

    $

    61,013

     

     

    $

    (15,456

    )

     

     

    (25.3

    )%

     

     

    .

     

     

     

     

     

     

     

     

     

     

    Comparable sales growth (decline):

     

     

     

     

     

     

     

     

     

     

    Sally

     

     

    0.1

    %

     

     

    1.7

    %

     

    (160)

     

     

     bps

     

    BSG

     

     

    (0.2

    )%

     

     

    1.4

    %

     

    (160)

     

     

     bps

     

    Consolidated

     

     

    —

     

     

     

    1.6

    %

     

    (160)

     

     

     bps

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Number of stores at end-of-period (including franchises):

     

     

     

     

     

     

     

    Sally

     

     

    3,090

     

     

     

    3,123

     

     

     

    (33

    )

     

     

    (1.1

    )%

    BSG

     

     

    1,325

     

     

     

    1,330

     

     

     

    (5

    )

     

     

    (0.4

    )%

    Consolidated

     

     

    4,415

     

     

     

    4,453

     

     

     

    (38

    )

     

     

    (0.9

    )%

     

    (a)
    Unallocated expenses consist of corporate and shared costs and are included in selling, general and administrative expenses in our condensed consolidated statements of earnings. Additionally, unallocated expenses include costs associated with our Fuel for Growth initiative as well as the $26.6 gain related to the sale of our corporate headquarters during the three months ended December 31, 2024. See Note 7, Property and Equipment, Net, for more information related to the sale of our corporate headquarters.

    17


     

    Results of Operations

    The Three Months Ended December 31, 2025, compared to the Three Months Ended December 31, 2024

    Net Sales

    Sally. The increase in net sales for Sally was primarily driven by the following (in thousands):

    Comparable sales

     

    $

    579

     

    Sales outside comparable sales (a)

     

     

    (2,795

    )

    Foreign currency exchange

     

     

    8,371

     

    Total

     

    $

    6,155

     

    (a)
    Includes closed stores, net of stores opened for less than 14 months.

    Sally's net sales increase was primarily driven by positive impacts from foreign exchange rates and a slight increase in comparable sales, partially offset by net stores closed during the past twelve months. The slight increase in comparable sales was primarily driven by strong growth in hair color and digital marketplaces, partially offset by external factors that impacted consumer spending, including the U.S. government shutdown, exiting substantially all of our full service operations across Europe, and softness in our hair care category. Sally’s comparable sales reflect an increase in average unit retail, partially offset by a decrease in transactions.

    BSG. The decrease in net sales for BSG was primarily driven by the following (in thousands):

    Comparable sales

     

    $

    (752

    )

    Sales outside comparable sales (a)

     

     

    (272

    )

    Foreign currency exchange

     

     

    142

     

    Total

     

    $

    (882

    )

    (a)
    Includes closed stores, net of stores opened for less than 14 months and sales from acquired stores.

    BSG's net sales decrease was primarily from a decrease in comparable sales. The decrease in comparable sales was driven by external factors that impacted stylist purchasing behavior, including the U.S. government shutdown, partially offset by strong performance in our color category. BSG's comparable sales decrease was primarily a result of fewer average number of units per transaction and a decrease in transactions, partially offset by an increase in average unit retail.

    Gross Profit

    Sally. Sally’s gross profit increased for the three months ended December 31, 2025, as a result of an increase in net sales and a higher gross margin on units sold. Sally’s gross margin improvement was driven primarily by higher product margins, resulting from benefits from our Fuel for Growth initiative.

    BSG. BSG’s gross profit increased for the three months ended December 31, 2025, as a result of a higher gross margin on units sold, partially offset by a decrease in net sales. BSG’s gross margin improvement was driven by higher product margins, resulting from benefits from our Fuel for Growth initiative.

    Selling, General and Administrative Expenses

    Sally. Sally’s selling, general and administrative expenses increased $6.7 million, or 2.9%, for the three months ended December 31, 2025, and included an unfavorable impact from foreign exchange rates of $3.5 million. As a percentage of Sally net sales, selling, general and administrative expenses for the three months ended December 31, 2025, were 45.2%, compared to 44.4% for the three months ended December 31, 2024. The increase as a percentage of sales was primarily due to increased labor and other compensation-related expenses, higher delivery and commission costs from digital marketplaces, and higher rent and advertising expenses, partially offset by Fuel for Growth benefits.

    BSG. BSG’s selling, general and administrative expenses decreased $1.7 million, or 1.5%, for the three months ended December 31, 2025. As a percentage of BSG net sales, selling, general and administrative expenses for the three months ended December 31, 2025, were 27.1% compared to 27.4% for the three months ended December 31, 2024. The decrease as a percentage of sales was primarily due to lower labor and other compensation-related expenses.

    Unallocated. Unallocated selling, general and administrative expenses, which represent certain corporate costs that have not been charged to our reporting segments, increased $25.8 million, or 86.1%, for the three months ended December 31, 2025, primarily due to a $26.6 million gain on the sale of our corporate headquarters in the prior year.

    Interest Expense

    The decrease in interest expense was primarily a result of a lower average outstanding principal balance on our Term Loan B. See Note 10, Short-term and Long-term Debt, in Item 1 of this quarterly report for more information on our debt.

    18


     

    Provision for Income Taxes

    The effective tax rates were 25.7% and 26.4% for the three months ended December 31, 2025 and 2024, respectively. The decrease in the effective tax rate was primarily due to the tax impact of share-based compensation which was beneficial in the current quarter, but detrimental in the prior year quarter, and a foreign loss in the prior year quarter for which a tax benefit was not recognized, offset by higher federal tax credits in the prior year quarter.

    Liquidity and Capital Resources

    Overview

    Our principal sources of liquidity are cash from operations, cash and cash equivalents and borrowings under our ABL facility. A substantial portion of our liquidity needs arise from funding the costs of our operations, working capital, capital expenditures, debt interest and principal payments. Additionally, under our share repurchase program (see below for more details) we will from time to time repurchase shares of our common stock on the open market to return value to our shareholders. At December 31, 2025, we had $639.6 million of available liquidity, which includes $482.4 million available for borrowing under our ABL facility and cash and cash equivalents of $157.2 million.

    Our working capital (current assets less current liabilities) increased $18.0 million, to $743.5 million at December 31, 2025, compared to $725.5 million at September 30, 2025. The increase was primarily driven by the timing of accrued compensation expenses within accrued expenses, timing of accounts payable, an increase in cash and cash equivalents, partially offset by the timing of income taxes payable, lower inventory, and the collection of landlord receivables related to our new corporate headquarters within accounts receivable, other.

    We anticipate that existing cash balances (excluding certain amounts permanently invested in connection with foreign operations), cash expected to be generated by operations, and funds available under our ABL facility will be sufficient to fund our working capital and capital expenditure requirements over the next twelve months.

    Cash Flows

     

     

    Three Months Ended December 31,

     

    (in thousands)

     

    2025

     

     

    2024

     

    Net cash provided by operating activities

     

    $

    93,239

     

     

    $

    33,457

     

    Net cash (used) provided by investing activities

     

     

    (35,784

    )

     

     

    23,125

     

    Net cash used by financing activities

     

     

    (47,886

    )

     

     

    (57,667

    )

    Net Cash Provided by Operating Activities

    The increase in cash provided by operating activities was primarily driven by the timing of accounts payable, lower income taxes paid, and the receipt of landlord receivables related to our new corporate headquarters.

    Net Cash (Used) Provided by Investing Activities

    The change in our investing activities was a result of lapping the cash received of $44.0 million from the sale of our corporate headquarters in the prior year and higher capital expenditures in the current year, which includes the build out of our new corporate headquarters.

    Net Cash Used by Financing Activities

    The decrease in cash used by financing activities was primarily driven by lower debt repayments in the current year, partially offset by higher share repurchases under our share repurchase program.

    Debt and Guarantor Financial Information

    At December 31, 2025, we had $855.0 million in outstanding debt principal, excluding unamortized debt issuance costs and debt discounts, in the aggregate, of $8.5 million. Our debt consists of $600.0 million in 2032 Senior Notes outstanding, and $255.0 million remaining on our Term Loan B. There were no outstanding borrowings under our ABL facility.

    We utilize our ABL facility for the issuance of letters of credit, certain working capital and liquidity needs, and to manage normal fluctuations in our operational cash flow. In that regard, we may from time to time draw funds under the ABL facility for general corporate purposes including funding of capital expenditures, acquisitions, paying down other debt and share repurchases. Amounts drawn on our ABL facility are generally paid down with cash provided by our operating activities. During the three months ended December 31, 2025, there were no borrowings under the ABL facility.

    We are currently in compliance with the agreements and instruments governing our debt, including our financial covenants.

    19


     

    Guarantor Financial Information

    Our 2032 Senior Notes were issued by our wholly owned subsidiaries, Sally Holdings LLC and Sally Capital Inc. (together, the “Issuers”). The notes are unsecured debt instruments guaranteed by us and certain of our wholly owned domestic subsidiaries (together, the “Guarantors”) and have certain restrictions on the ability of our subsidiaries to make certain restrictive payments to Sally Beauty. The guarantees are joint and several, and full and unconditional. Certain other subsidiaries, including our foreign subsidiaries, do not serve as guarantors.

    The following summarized consolidating financial information represents financial information for the Issuers and the Guarantors on a combined basis. All transactions and intercompany balances between these combined entities have been eliminated.

    The following table presents the summarized balance sheets information for the Issuers and the Guarantors as of December 31, 2025, and September 30, 2025:

    (in thousands)

     

    December 31, 2025

     

     

    September 30, 2025

     

    Cash and cash equivalents

     

    $

    88,091

     

     

    $

    85,360

     

    Inventory

     

    $

    718,863

     

     

    $

    721,975

     

    Current assets

     

    $

    914,069

     

     

    $

    927,667

     

    Total assets

     

    $

    2,159,366

     

     

    $

    2,177,968

     

    Intercompany payable

     

    $

    17,495

     

     

    $

    15,117

     

    Current liabilities

     

    $

    452,242

     

     

    $

    474,079

     

    Total liabilities

     

    $

    1,845,058

     

     

    $

    1,883,754

     

    The following table presents the summarized statement of earnings information for the Issuers and the Guarantors for the three months ended December 31, 2025 (in thousands):

    Net sales

     

    $

    755,683

     

     

    Gross profit

     

    $

    394,766

     

     

    Earnings before provision for income taxes

     

    $

    51,588

     

     

    Net Earnings

     

    $

    38,294

     

     

    Share Repurchase Programs

    Under our current share repurchase program, we may from time to time repurchase our common stock on the open market. During the three months ended December 31, 2025 and 2024, we repurchased 1.4 million shares and 0.8 million shares of our common stock for $20.7 million and $10.0 million, respectively, under our share repurchase program, excluding the impact of excise taxes. See Note 5, Stockholders’ Equity, for more information about our share repurchase program.

    Contractual Obligations

    Other than our debt, as discussed above, there have been no material changes outside the ordinary course of our business to our contractual obligations since September 30, 2025.

    Off-Balance Sheet Financing Arrangements

    At December 31, 2025, and September 30, 2025, we had no off-balance sheet financing arrangements other than outstanding letters of credit related to inventory purchases and self-insurance programs.

    Critical Accounting Estimates

    There have been no material changes to our critical accounting estimates or assumptions since September 30, 2025.

    Recent Accounting Pronouncements

    See Note 2 of the Notes to Condensed Consolidated Financial Statements in Item 1 – “Financial Statements” in Part I – Financial Information.

    20


     

    Item 3. Quantitative and Qualitative Disclosures About Market Risk

    As a multinational corporation, we are subject to certain market risks including foreign currency fluctuations, interest rates and government actions. There have been no material changes to our market risks from September 30, 2025. See our disclosures about market risks contained in Item 7A. “Quantitative and Qualitative Disclosures about Market Risk” in Part II of our Annual Report on Form 10-K for the fiscal year ended September 30, 2025.

    Item 4. Controls and Procedures

    Controls Evaluation and Related CEO and CFO Certifications. Our management, with the participation of our principal executive officer (“CEO”) and principal financial officer (“CFO”), conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2025. The controls evaluation was conducted by our Disclosure Committee, comprised of senior representatives from our finance, accounting, internal audit, and legal departments under the supervision of our CEO and CFO.

    Certifications of our CEO and our CFO, which are required in accordance with Rule 13a-14 of the Exchange Act, are attached as exhibits to this Quarterly Report. This “Controls and Procedures” section includes the information concerning the controls evaluation referred to in the certifications, and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.

    Limitations on the Effectiveness of Controls. We do not expect that our disclosure controls and procedures will prevent all errors and all fraud. A system of controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the system are met. Because of the limitations in all such systems, no evaluation can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. Furthermore, the design of any system of controls and procedures is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how unlikely. Because of these inherent limitations in a cost-effective system of controls and procedures, misstatements or omissions due to error or fraud may occur and not be detected.

    Scope of the Controls Evaluation. The evaluation of our disclosure controls and procedures included a review of their objectives and design, our implementation of the controls and procedures and the effect of the controls and procedures on the information generated for use in this Quarterly Report. In the course of the evaluation, we sought to identify whether we had any data errors, control problems or acts of fraud and to confirm that appropriate corrective action, including process improvements, was being undertaken if needed. This type of evaluation is performed on a quarterly basis so that conclusions concerning the effectiveness of our disclosure controls and procedures can be reported in our Quarterly Reports on Form 10-Q and our Annual Reports on Form 10-K. Many of the components of our disclosure controls and procedures are also evaluated by our internal audit department, by our legal department and by personnel in our finance organization. The overall goals of these various evaluation activities are to monitor our disclosure controls and procedures on an ongoing basis and to maintain them as dynamic systems that change as conditions warrant.

    Conclusions regarding Disclosure Controls. Based on the required evaluation of our disclosure controls and procedures, our CEO and CFO have concluded that, as of December 31, 2025, we maintain disclosure controls and procedures that are effective in providing reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

    Changes in Internal Control over Financial Reporting. During our most recent fiscal quarter, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

     

    21


     

    PART II — OTHER INFORMATION

    Item 1. Legal Proceedings

    We are involved, from time to time, in various claims and lawsuits incidental to the conduct of our business in the ordinary course. We carry insurance coverage in such amounts in excess of our self-insured retention as we believe to be reasonable under the circumstances and that may or may not cover any or all of our liabilities in respect of these matters. We do not believe that the ultimate resolution of these matters will have a material adverse impact on our consolidated financial position, cash flows or results of operations.

    We are subject to a number of U.S., federal, state and local laws and regulations, as well as the laws and regulations applicable in each foreign country or jurisdiction in which we do business. These laws and regulations govern, among other things, the composition, packaging, labeling and safety of the products we sell, the methods we use to sell these products and the methods we use to import these products. We believe that we are in material compliance with such laws and regulations, although no assurance can be provided that this will remain true going forward.

    Item 1A. Risk Factors

    In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors contained in Item 1A. “Risk Factors” in Part I of our Annual Report on Form 10-K for the fiscal year ended September 30, 2025, which could materially affect our business, financial condition or future results. There have been no material changes from the risk factors disclosed in such Annual Report. The risks described in such Annual Report and herein are not the only risks facing our company.

    Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities

    Information regarding shares of common stock we repurchased during the quarter ended December 31, 2025, excluding the impact of excise taxes, is as follows:

    Fiscal Period

     

    Total Number of Shares Purchased (1)

     

     

    Average Price Paid per Share (2)

     

     

    Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)(3)

     

     

    Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs

     

    Oct 1 - Oct 31, 2025

     

     

    306,443

     

     

    $

    15.35

     

     

     

    306,443

     

     

    $

    462,608,222

     

    Nov 1 - Nov 30, 2025

     

     

    394,097

     

     

     

    14.77

     

     

     

    394,097

     

     

     

    456,786,017

     

    Dec 1 - Dec 31, 2025

     

     

    658,732

     

     

     

    15.42

     

     

     

    658,732

     

     

     

    446,628,419

     

    Total this quarter

     

     

    1,359,272

     

     

    $

    15.22

     

     

     

    1,359,272

     

     

    $

    446,628,419

     

     

    (1)
    The table above does not include 517,190 shares of our common stock surrendered by grantees during the quarter to satisfy tax withholding obligations due upon the vesting of equity-based awards under our share-based compensation plans.
    (2)
    The calculation of the average price paid per share includes the impact of commissions paid in connection with the shares repurchased.
    (3)
    In May 2025, our Board approved a term extension through September 30, 2029, of our share repurchase program to repurchase up to $1.0 billion of our common stock, which was originally approved in August 2017.

    Item 5. Other Information

    Adoption or Termination of Rule 10b5-1 Trading Plans

    On December 10, 2025, President of Sally, John Goss, adopted a trading arrangement for the sale of the Company’s common stock that is intended to satisfy the affirmative defense conditions of the Securities Exchange Act Rule 10b5-1(c) (a “Rule 10b5-1 trading plan”). Mr. Goss’ Rule 10b5-1 trading plan will be effective on March 13, 2026, and terminates at the close of trading on November 15, 2026, or sooner upon certain events. Mr. Goss’ Rule 10b5-1 trading plan provides for the sale of up to 50,000 shares of the Company’s common stock pursuant to the terms of such plan.

    22


     

    Item 6. Exhibits

     

    Exhibit No.

    Description

     

     

     

    3.1

    Third Restated Certificate of Incorporation of Sally Beauty Holdings, Inc., dated January 30, 2014, which is incorporated herein by reference from Exhibit 3.3 to the Company’s Current Report on Form 8-K filed on January 30, 2014

    3.2

    Amended and Restated By-Laws of Sally Beauty Holdings, Inc., dated July 2, 2025, which is incorporated herein by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on July 9, 2025

     

     

     

    22*

     

    List of Subsidiary Guarantors

     

     

     

    31.1*

    Rule 13a-14(a)/15d-14(a) Certification of Denise Paulonis

    31.2*

    Rule 13a-14(a)/15d-14(a) Certification of Marlo M. Cormier

    32.1*

    Section 1350 Certification of Denise Paulonis

    32.2*

    Section 1350 Certification of Marlo M. Cormier

     

     

     

    101

    The following financial information from our Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2025, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Earnings; (iii) the Condensed Consolidated Statements of Comprehensive Income; (iv) the Condensed Consolidated Statements of Stockholders’ Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) the Notes to Condensed Consolidated Financial Statements.

     

     

     

    104

    The cover page from our Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2025, formatted in iXBRL (contained in Exhibit 101).

    * Included herewith

     

    23


     

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     

     

     

    SALLY BEAUTY HOLDINGS, INC.

     

     

     

    (Registrant)

     

     

     

     

    Date: February 9, 2026

     

     

     

     

     

     

     

     

    By:

     

    /s/ Marlo M. Cormier

     

     

     

    Marlo M. Cormier

     

     

     

    Senior Vice President, Chief Financial Officer

     

     

     

    For the Registrant and as its Principal Financial Officer

     

    24


    Get the next $SBH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SBH

    DatePrice TargetRatingAnalyst
    1/21/2026$19.00Mkt Perform → Outperform
    Raymond James
    1/14/2026$16.00Buy → Hold
    Jefferies
    1/16/2025$14.00Buy
    Canaccord Genuity
    11/25/2024$14.00 → $16.00Hold → Buy
    TD Cowen
    11/15/2024Underperform → Mkt Perform
    Raymond James
    12/15/2022$15.00Overweight
    Piper Sandler
    8/12/2022$17.00Outperform → Market Perform
    Cowen
    6/29/2022Mkt Perform → Underperform
    Raymond James
    More analyst ratings

    $SBH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sally Beauty Holdings Reports First Quarter Fiscal 2026 Results

    Q1 Consolidated Net Sales Increased 0.6%; Consolidated Comparable Sales Flat Q1 GAAP Diluted EPS Decreased 22%; Adjusted Diluted EPS Increased 12% Q1 Cash Flow from Operations of $93 Million Deployed to Invest for Growth, Strengthen Balance Sheet and Return Value to Shareholders Company Raises Low End of Fiscal 2026 EPS Guidance Sally Beauty Holdings, Inc. (NYSE:SBH) (the "Company"), the leader in professional hair color, today announced financial results for its first quarter ended December 31, 2025. The Company will hold a conference call today at 7:30 a.m. Central Time to discuss these results and its business. "Our first quarter performance marks a strong start to fiscal

    2/9/26 6:45:00 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    Sally Beauty Is Prioritizing Innovation Reinforcing Its Leadership in Hair

    The beauty retailer is introducing category-expanding products with best-in-class innovation designed to meet the evolving needs of today's beauty consumer, only at Sally. PLANO, Texas, Jan. 27, 2026 /PRNewswire/ -- Sally Beauty, the industry-leading destination for professional-quality hair color, hair care, and nails, is expanding its innovation pipeline with advanced formulas and technology. designed to make high-performance beauty more accessible and affordable. Sally Beauty is debuting ion® 24K, a new collection within the retailer's largest brand, ion. In a recent survey

    1/27/26 4:23:00 PM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    Sally Beauty Holdings Announces Conference Call and Webcast to Discuss First Quarter Financial Results on February 9, 2026

    Sally Beauty Holdings, Inc. (NYSE:SBH) (the "Company"), the leader in professional hair color, announced today that it will host a conference call and webcast on February 9, 2026, at 7:30 a.m. Central Time, to discuss its first quarter financial results. A copy of the press release announcing the first quarter financial results is expected to be made available on February 9, 2026, before the U.S. financial markets open on the Company's website sallybeautyholdings.com/investor-relations. During the conference call, the Company may discuss and answer one or more questions concerning business and financial matters and trends affecting the Company. The Company's responses to these questions,

    1/26/26 12:00:00 PM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    $SBH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Sally Beauty upgraded by Raymond James with a new price target

    Raymond James upgraded Sally Beauty from Mkt Perform to Outperform and set a new price target of $19.00

    1/21/26 8:30:43 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    Sally Beauty downgraded by Jefferies with a new price target

    Jefferies downgraded Sally Beauty from Buy to Hold and set a new price target of $16.00

    1/14/26 8:27:37 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    Canaccord Genuity initiated coverage on Sally Beauty with a new price target

    Canaccord Genuity initiated coverage of Sally Beauty with a rating of Buy and set a new price target of $14.00

    1/16/25 7:54:11 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    $SBH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Head James M

    4 - Sally Beauty Holdings, Inc. (0001368458) (Issuer)

    1/26/26 8:00:13 PM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 4 filed by Director Cox Erin Nealy

    4 - Sally Beauty Holdings, Inc. (0001368458) (Issuer)

    1/26/26 8:00:15 PM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    Director Bishop Rachel Rothe converted options into 14,532 shares, increasing direct ownership by 67% to 36,231 units (SEC Form 4)

    4 - Sally Beauty Holdings, Inc. (0001368458) (Issuer)

    1/26/26 8:00:12 PM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    $SBH
    SEC Filings

    View All

    SEC Form 10-Q filed by Sally Beauty Holdings Inc. (Name to be changed from Sally Hold

    10-Q - Sally Beauty Holdings, Inc. (0001368458) (Filer)

    2/9/26 4:06:31 PM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 8-K filed by Sally Beauty Holdings Inc. (Name to be changed from Sally Hold

    8-K - Sally Beauty Holdings, Inc. (0001368458) (Filer)

    2/9/26 6:45:16 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    Sally Beauty Holdings Inc. (Name to be changed from Sally Hold filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Sally Beauty Holdings, Inc. (0001368458) (Filer)

    1/26/26 5:00:23 PM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    $SBH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rangel Max R. bought $49,239 worth of shares (3,500 units at $14.07) (SEC Form 4)

    4 - Sally Beauty Holdings, Inc. (0001368458) (Issuer)

    9/8/25 9:00:05 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    Director Perelman Debra Golding bought $31,011 worth of shares (2,300 units at $13.48) (SEC Form 4)

    4 - Sally Beauty Holdings, Inc. (0001368458) (Issuer)

    8/14/25 5:53:19 PM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    President & CEO Paulonis Denise bought $52,830 worth of shares (4,500 units at $11.74), increasing direct ownership by 1% to 366,865 units (SEC Form 4)

    4 - Sally Beauty Holdings, Inc. (0001368458) (Issuer)

    8/11/25 2:18:19 PM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    $SBH
    Leadership Updates

    Live Leadership Updates

    View All

    Sally Beauty Holdings Appoints Max Rangel to Board of Directors

    Sally Beauty Holdings, Inc. (NYSE:SBH) today announced the appointment of Max Rangel, consumer products industry veteran and Global President and CEO of Spin Master Corporation, to its Board of Directors, effective immediately. "We are very pleased to have Max join our Board of Directors and bring his C-suite experience and industry expertise gained from more than three decades at consumer goods companies including Procter & Gamble, The Hershey Company, and S.C. Johnson & Son," said Diana Ferguson, Chair of SBH's Board. "Max is a seasoned executive with experience driving operational excellence along with brand transformation, innovative marketing, and growth across leading global compani

    6/18/25 6:45:00 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    Sally Beauty Expands Award-Winning Styling Tool Collection with ion Luxe 8-In-1 Airstyler Pro

    The ion Luxe 8-In-1 Airstyler Pro Revolutionizes Hairstyling With an All-In-One Tool for Everyone. DENTON, Texas, Oct. 24, 2024 /PRNewswire/ -- Sally Beauty, the industry-leading destination for professional quality hair color and care, unveils the latest styling tool to join ion's award-winning line-up. The ion Luxe 8-In-1 Airstyler Pro transforms the hairstyling experience, enabling consumers to gently style their hair with air to minimize damage from heat. This new tool offers consumers the same negative ion technology as the ion Luxe 4-In-1 Autowrap™ Airstyler, which went viral across social media. Backed by a strong reputation for innovation and value, ion is Sally Beauty's largest own

    10/24/24 9:03:00 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    Introducing Freewill: The Personalized Haircare Brand Designed to Unlock Your Hair's Full Potential

    Co-developed with Sally Beauty, Freewill's customizable, salon-quality products harness the power of hair cycling, giving you your best hair yet Underlining, leading beauty brand developer, announced today the launch of Freewill, a salon-quality, customizable haircare brand crafted for hair cycling. The collection, co-developed with Sally Beauty, the leader in professional hair color and care, is designed to support every hair type, at every stage, encouraging rotation through tailored routines. Covering all categories including Scalp & Detox, Volume Boost, Smooth & Sleek, Restorative Repair, Curls & Coils, Color Care, and Blonde Care, Freewill features 32 products that are ‘Mindful At Sa

    8/1/24 9:01:00 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    $SBH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sally Beauty Holdings Inc. (Name to be changed from Sally Hold

    SC 13G/A - Sally Beauty Holdings, Inc. (0001368458) (Subject)

    11/12/24 4:51:33 PM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Sally Beauty Holdings Inc. (Name to be changed from Sally Hold

    SC 13G/A - Sally Beauty Holdings, Inc. (0001368458) (Subject)

    11/4/24 1:53:26 PM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    SEC Form SC 13G/A filed by Sally Beauty Holdings Inc. (Name to be changed from Sally Hold (Amendment)

    SC 13G/A - Sally Beauty Holdings, Inc. (0001368458) (Subject)

    2/14/24 3:39:16 PM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    $SBH
    Financials

    Live finance-specific insights

    View All

    Sally Beauty Holdings Announces Conference Call and Webcast to Discuss First Quarter Financial Results on February 9, 2026

    Sally Beauty Holdings, Inc. (NYSE:SBH) (the "Company"), the leader in professional hair color, announced today that it will host a conference call and webcast on February 9, 2026, at 7:30 a.m. Central Time, to discuss its first quarter financial results. A copy of the press release announcing the first quarter financial results is expected to be made available on February 9, 2026, before the U.S. financial markets open on the Company's website sallybeautyholdings.com/investor-relations. During the conference call, the Company may discuss and answer one or more questions concerning business and financial matters and trends affecting the Company. The Company's responses to these questions,

    1/26/26 12:00:00 PM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    Sally Beauty Holdings Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year Financial Results on November 13, 2025

    Virtual Annual Meeting of Stockholders Scheduled for January 26, 2026 Sally Beauty Holdings, Inc. (NYSE:SBH) (the "Company"), the leader in professional hair color, announced today that it will host a conference call and webcast on November 13, 2025, at 7:30 a.m. Central Time, to discuss its fourth quarter and full year financial results. A copy of the press release announcing the fourth quarter and full year financial results is expected to be made available on November 13, 2025, before the U.S. financial markets open on the Company's website sallybeautyholdings.com/investor-relations. During the conference call, the Company may discuss and answer one or more questions concerning busin

    10/31/25 6:45:00 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    Sally Beauty Holdings Reports Third Quarter Fiscal 2025 Results

    Fuel for Growth Program Yields Fourth Consecutive Quarter of Operating Margin Expansion and Double-Digit EPS Growth Strengthens Balance Sheet Adjusts Full Year Comparable Sales Outlook to High End of Prior Range Raises Full Year Adjusted Operating Margin Guidance Sally Beauty Holdings, Inc. (NYSE:SBH) (the "Company"), the leader in professional hair color, today announced financial results for its third quarter ended June 30, 2025. The Company will hold a conference call today at 7:30 a.m. Central Time to discuss these results and its business. Fiscal 2025 Third Quarter Summary Consolidated net sales of $933 million, a decrease of 1.0% compared to the prior year; Consol

    8/5/25 6:45:00 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary